Nonstructural protein 1 (NS1) of minute virus of mice is involved in viral DNA replication, transcriptional regulation and cytotoxic action in the host cell. Viral DNA replication is dependent on the ability of NS1 to form homo-oligomers. To investigate whether oligomerization is required for NS1 transcriptional activities, a functionally impaired mutant derivative of NS1 that was able to interact with the wild-type (wt) protein and inhibit its activity in a dominant-negative manner was designed. This mutant provided evidence that transactivation of the parvoviral P38 promoter and transinhibition of a heterologous promoter by NS1 were both affected by the co-expression of the wt and the dominant-negative mutant form of NS1. These results indicate that additional functions of NS1, involved in promoter regulation, require oligomer formation.
Nonstructural protein 1 (NS1) of minute virus of mice is involved in viral DNA replication, transcriptional regulation and cytotoxic action in the host cell. Viral DNA replication is dependent on the ability of NS1 to form homo-oligomers. To investigate whether oligomerization is required for NS1 transcriptional activities, a functionally impaired mutant derivative of NS1 that was able to interact with the wild-type (wt) protein and inhibit its activity in a dominant-negative manner was designed. This mutant provided evidence that transactivation of the parvoviral P38 promoter and transinhibition of a heterologous promoter by NS1 were both affected by the co-expression of the wt and the dominant-negative mutant form of NS1. These results indicate that additional functions of NS1, involved in promoter regulation, require oligomer formation.
Autonomous parvoviruses are small non-enveloped viruses that infect a variety of animal species, including humans. Their 5 kb genome is a linear single-stranded DNA molecule flanked by palindromic sequences. The coding sequence of the prototype strain of minute virus of mice (MVMp) used in the present study is divided into two overlapping transcription units (Pintel et al., 1983 ) that encode two capsid proteins (VP) and at least four non-structural (NS) proteins (Cotmore & Tattersall, 1987) . Of these latter polypeptides, NS1, an 83 kDa nuclear phosphoprotein, is the only polypeptide essential for a productive infection in all cell types (Cater & Pintel, 1992 ; Naeger et al., 1990) . NS1 is endowed with intrinsic ATPase, site-specific endonuclease, helicase and DNA-binding activities (Baldauf et al., 1997 ; Christensen et al., 1997 ; Cotmore & Tattersall, 1998 ; Nu$ esch et al., 1995 ; Wilson et al., 1991) . These various functions are involved in viral DNA replication and transcription, which allows NS1 to serve both as an initiator of viral DNA amplification and as a regulator of viral gene expression. NS1 strongly induces the viral P38 promoter (Rhode & Richard, 1987) and activates or inhibits gene expression from heterologous promoters (Faisst et al., 1993 ; Legendre & Rommelaere, 1992 ; Vanacker et al., 1993) . Although the molecular mechanisms involved in these various effects are still elusive, genetic analysis has shown that the transcription-regulating domains of NS1 are confined to the amino-and carboxy-terminal portions of the protein and can be dissociated from its replicative function (Legendre & Rommelaere, 1992) .
To be fully functional, a number of proteins involved in DNA metabolism require self-association. This is the case of most helicases (West, 1996) , many replication and transcription factors (Baler et al., 1993 ; Lazazzera et al., 1996 ; Mastrangelo et al., 1991) , and multifunctional proteins, such as the large tumour antigen of simian virus 40 (SV40) (San Martin et al., 1997) . Transcription factors forming oligomers can be inactivated in a dominant-negative manner by co-expressing a non-functional derivative capable of associating with the wildtype (wt) protein and forming inactive oligomers (Smith & Birrer, 1996) . Recently, it was demonstrated that NS1 is able to form homo-oligomers in an ATP-dependent manner (Nu$ esch & Tattersall, 1993) . This self-association is required for NS1 to fulfill its helicase function and to support viral DNA replication (Pujol et al., 1997) . In order to study promoter regulation by NS1, we used this observation to design an approach involving a dominant-negative mutant. We engineered a mutant form of NS1 that is non-functional with regard to transcriptional activities and unable to bind to its DNA recognition motif, but can still oligomerize with full-length NS1. Should such a mutant act in a dominant-negative manner, this would argue for a role of self-association in the transcription-regulating functions of NS1. A putative dominant-negative mutant NS1 derivative, ∆DT, which is unable to bind to its DNA cognate motif (deletion of aa 95-254) and lacks the acidic activation domain (deletion of 67 aa from the C terminus), but contains the oligomerization domain, was designed. A control mutant, ∆DOT, which is identical to the ∆DT mutant but impaired for oligomerization due to a deletion within the domain required for self-association (VETTVT-X * -IQT) was also constructed ( Fig. 1 A) (Pujol et al., 1997) . All constructs were engineered by PCR using the wt NS1 DNA sequence and cloned into the cytomegalovirus (CMV)-driven expression vector pX (Pujol et al., 1997) . The two different mutant derivatives were expressed at similar levels, as shown by immuno-blotting of extracts prepared from A9 cells transfected with a construct harbouring NS1 under the control of the bacteriophage T7 promoter and infected with a recombinant vaccinia virus, vTF7-3, expressing the bacteriophage T7 RNA polymerase (Fig. 1 B) (Nu$ esch et al., 1992) . By two-hybrid analysis, the ∆O deletion of aa 277-309 has been shown to prevent NS1 from homo-oligomerization (Pujol et al., 1997) .
NS1 exhibits a mainly nuclear localization during natural MVM infection (Cotmore et al., 1986) and when produced independently of other parvoviral proteins or viral DNA in transient expression systems (Nu$ esch et al., 1992 ; Nu$ esch & Tattersall, 1993) . Previously, it has been shown that mutant NS1 polypeptides with an impaired nuclear localization signal (NLS) display nuclear localization when co-expressed with wt NS1. Plasmids expressing wt NS1, FLAG-NS1 ∆DT or FLAG-NS1 ∆DOT, under the control of the CMV early promoter were transfected separately into A9 cells. At 36 h posttransfection, proteins were detected by double-immunofluorescence using an M2 monoclonal antibody (Kodak), which recognizes the FLAG epitope, together with the polyclonal antisera SP8 (Brockhaus et al., 1996) , which recognizes the C terminus of NS1 absent in the ∆DT and ∆DOT proteins. Immunofluorescence staining was analysed by confocal laser microscopy. As presented in Fig. 2 (A) , wt NS was found mainly in the nucleus of A9 cells, as described previously (Nu$ esch et al., 1992) . As expected from the lack of the NLS in the mutant forms (Fig. 1) , the ∆DT derivative only displayed cytoplasmic localization, while the ∆DOT mutant exhibited uniform distribution between the cytoplasm and the nucleus (Fig. 2 C) . The migration of ∆DOT into the nucleus is most likely due to both the small size of this mutant (55 kDa) and its inability to form higher order oligomers, which may allow the polypeptide to enter the nucleus independently of an NLS. When A9 cells were co-transfected with pX-NS1 wt and pX-FLAG-NS1 ∆DT at a ratio of 1 : 1, the ∆DT mutant co-localized with wt NS1 in the nuclear compartment (Fig. 2 D) . In contrast, A9 cells co-transfected with ∆DOT-and wt NS1-expressing vectors showed no co-localization of mutant ∆DOT with wt NS1 (Fig. 2 E) . These findings clearly indicate that the ability of ∆DT to interact with NS1 is due to the self-association domain, as ∆DOT, which lacks this domain, fails to associate with wt NS1.
The parvoviral P38 promoter is activated in the presence of wt NS1. Transcriptional activation mediated by NS1 is dependent on site-specific interaction of NS1 with its cognate DNA-binding motif, which is located within the tar region of the promoter (Christensen et al., 1995) , as well as NS1 interaction with the transcription factor SP1 (Krady & Ward, 1995 ; Lorson et al., 1998) . In order to investigate whether oligomerization of NS1 is indeed a prerequisite for its ability to transactivate the P38 promoter, we attempted to inhibit the activity of wt NS1 by co-expression with ∆DT that was Cterminally fused to the SV40 large tumour antigen NLS allowing migration to the nucleus as confirmed by immunofluorescence (data not shown). The plasmid P38-Luc, which contains the luciferase gene under the control of the MVMp P38 promoter, was used as a reporter to reveal the transactivation capacity of NS1 in transient expression assays. A9 mouse fibroblasts were co-transfected with 50 ng of P38-Luc and various amounts of pX, pX-NS1, pX-∆DT-NLS or pX-∆DOT-NLS. Luciferase activity was measured 36 h posttransfection. To exclude any effect of the pX plasmid on P38 promoter function, luciferase activities from extracts of cells transfected with P38-Luc in the presence or absence of 400 ng of pX were compared. Since no differences were found between the two conditions (data not shown), the total amount of the Oligomerization of NS1 from parvovirus MVMp Oligomerization of NS1 from parvovirus MVMp effector plasmid was maintained at 400 ng per transfection. As illustrated in Fig. 3 (A) , wt NS1 was able to transactivate the P38 promoter up to 100-fold above that of the background level detected with the pX control vector. In contrast, no significant transactivation was observed with NS1-∆DT-NLS or NS1-∆DOT-NLS. Using co-expression of either mutant 5 A9 cells were co-transfected with 50 ng of the reporter plasmid P38-Luc and indicated amounts of effector plasmid pX-NS1wt, pX-∆DT-NLS or pX-∆DOT-NLS. Effector plasmids were given either separately (A) or in combination (B). The DNA inoculum was adjusted to 400 ng with the control plasmid pX. Transfected cultures were incubated for 48 h and assayed for luciferase activity. The relative light units (RLU) measured for the P38 promoter-driven reporter plasmid co-transfected with each effector are shown (A) and the fold induction of the P38 promoter is shown for the different effectors (B). (C, D) The CMV early promoter-driven reporter construct pCMV SEAP was used to measure the transinhibiting effects of wt or mutant NS1-expressing plasmids that were inoculated either separately (C) or in combination (D). All transfection mixtures were adjusted to 600 ng of effector plasmid with the empty vector pX. SEAP activity was measured with the Phospha-Light kit (Tropix), according to the manufacturer's instructions. The RLU measured for the CMV promoter-driven reporter plasmid co-transfected with each effector are shown (C) and the fold inhibition of the CMV promoter is shown for the different effectors (D). Data are average values from three independent transfections, each carried out in triplicate. Oligomerization of NS1 from parvovirus MVMp Oligomerization of NS1 from parvovirus MVMp polypeptide with wt NS1, we determined whether interaction with ∆DT would impair NS1 capacity for transactivation. Mouse A9 cells were co-transfected with P38-Luc (reporter), pX-NS1 wt (transactivator) and the potential transinhibitor pX-∆DT-NLS (or pX-∆DOT-NLS as a negative control) in wt versus mutant ratios of 1 : 1, 1 : 3 or 1 : 6. As illustrated in Fig.  3 (B) , P38 transactivation by wt NS1 was reduced in cells coexpressing ∆DT-NLS in a dose-dependent manner. In contrast, the oligomerization-negative ∆DOT-NLS protein failed to suppress wt NS1-induced transactivation, even when supplied in a sixfold excess over pX-NS1 wt . The reduction of wt NS1-induced P38 activity in the presence of ∆DT, but not ∆DOT, under conditions in which target cells accumulate similar amount of both types of mutant proteins (Fig. 2) , argues for oligomerization as the mechanism by which the ∆DT form exerts its dominant-negative effect. This interpretation is supported by recent work that shows that NS1 directly binds, in an ATP-dependent manner, to a promoter P38 region that mediates the NS1 transactivation response in cis (Christensen et al., 1995) . The ATP-dependence of NS1-specific binding to DNA can be circumvented in the presence of antibodies that are likely to cross-link NS1 molecules. These data, together with the footprinting analysis of NS1-DNA interactions (Christensen et al., 1995) , point to the fact that NS1 homooligomerization is involved in specific DNA binding and ensuing promoter transactivation. This is in keeping with the proposed mode of action whereby the dominant-negative ∆DT mutant forms inactive oligomers with wt NS1.
Besides regulating the viral P38 promoter, NS1 is also able to suppress transcription from a number of cellular and heterologous viral promoters (Legendre & Rommelaere, 1992 ; Rhode & Richard, 1987) . At present, it is not clear whether this inhibition results from a specific repression by NS1 or a mere squelching of transcription factors that interact with the N-or C-terminal domains of the polypeptides (Legendre & Rommelaere, 1992) . The dominant-negative mutant approach was used to investigate whether homooligomerization is involved in the transinhibiting activity of NS1. The early promoter of CMV was chosen as a target for NS1-dependent transinhibition. A fixed amount (50 ng) of an expression vector expressing secreted alkaline phosphatase (SEAP) from the CMV promoter (pCMV SEAP) (Tropix) was co-transfected with increasing amounts of plasmids expressing either wt NS1 or the mutant derivatives ∆DT-NLS or ∆DOT-NLS. The total amount of the effector plasmid was maintained at 400 ng per transfection for the same reason as that described for the P38 promoter. As illustrated in Fig. 3 (C) , wt NS1 suppressed CMV promoter activity by more than fourfold, whereas both of the deletion mutants were deficient in this respect. When plasmids expressing wt NS1 and ∆DT were cotransfected, the mutant polypeptide exerted a dominantnegative effect on the wt protein, in that it prevented the latter from transrepressing the CMV early promoter (Fig. 3 D) . In contrast, the oligomerization-deficient NS1 ∆DOT mutant form was ineffective in suppressing the transinhibitory activity of wt NS1. These results indicate that NS1-mediated transinhibition of the CMV promoter is achieved by a multimeric form of the polypeptide requiring functionally active subunits.
In conclusion, the NS1 ∆DT mutant protein proved able to negatively interfere with the capacity of wt NS1 for both activation and repression of target promoters in a way that is dependent on the self-association of the NS1 polypeptide. These data indicate that the transcription-regulating function of NS1 is likely to require NS1 homo-oligomerization. Further investigations are necessary to determine whether homooligomerization controls the interaction of NS1 with the transcription machinery and\or other transcription factors.
